Analyzing the Price Movement -- Analyst Research on Goldcorp, Questar, Dollar General and Novo Nordisk

NEW YORK, NY / ACCESSWIRE / February 9, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Goldcorp Inc. (NYSE: GG), Questar Corp. (NYSE: STR), Dollar General Corp. (NYSE: DG) and Novo Nordisk A/S (NYSE: NVO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

GG Research Package: http://www.traders-choice.com/pdf?s=GG

STR Research Package: http://www.traders-choice.com/pdf?s=STR

DG Research Package: http://www.traders-choice.com/pdf?s=DG

NVO Research Package: http://www.traders-choice.com/pdf?s=NVO

============

Highlights from today's reports include:

On Monday, February 8, 2016, NASDAQ Composite ended at 4,283.75 down 1.82%, Dow Jones Industrial Average declined 1.10%, to finish the day at 16,027.05, and the S&P 500 closed at 1,853.44, down 1.42%.

- Goldcorp Inc.'s stock edged higher by 7.21% to close Monday's session at USD 14.72. The company's shares oscillated between USD 14.30 and USD 15.12. The stock recorded a trading volume of 22.96 million shares, which was above its 50-day daily average volume of 9.36 million shares and its 52-week average volume of 9.03 million shares. Over the last three days Goldcorp Inc.'s shares have advanced 18.52% and in the past one week the stock has moved up 27.56%. Furthermore, over the last three months the stock has gained 23.28% and in the past six months the shares have picked up 2.51%. Goldcorp Inc. has a current dividend yield of 1.75%. The stock is trading at a price to book ratio of 0.70, compared to its historical PB ratio of 0.89. Additionally, the stock is trading at a price to cash flow ratio of 11.67 and a price to sales ratio of 3.12.

- The stock of Questar Corp. gained 0.28% to close Monday's session at USD 25.00. The shares of the company moved in the range of USD 24.88 and USD 25.12. A trading volume of 5.82 million shares was recorded, much greater than its 150-day daily average volume of 1.93 million shares and its 52-week average volume of 1.54 million shares. Over the last five days Questar Corp.'s shares have advanced 0.04% and in the past one month the stock has gained a momentum of 29.13%. Additionally, over the last three months the stock has advanced 33.40% and in the past six months the shares have registered a gain of 18.99%. Further, the company is trading at a price to earnings ratio of 20.16 and a price to book ratio of 3.37. Moreover, the stock is trading at a price to cash flow ratio of 8.38 and a price to sales ratio of 3.81.

- Dollar General Corp.'s stock decreased by 2.72% to close Monday's session at USD 69.71. The company's shares fluctuated in the range of USD 68.88 and USD 71.31. A total of 3.93 million shares exchanged hands, which surpassed its 50-day daily average volume of 3.44 million shares and its 52-week average volume of 3.46 million shares. Over the last three days Dollar General Corp.'s shares have declined by 7.18% and in the past one week the stock has moved down 8.70%. However, over the last three months the stock has gained 4.09% while in the past six months the shares have shed 11.49%. Dollar General Corp. has a current dividend yield of 1.23% and the stock has a beta of 0.37. Further, the company is trading at a price to earnings ratio of 18.25 and a price to book ratio of 3.90, compared to its historical PE ratio of 19.24 and a historical PB ratio of 3.56.

- Novo Nordisk A/S's shares slipped by 3.84% to close Monday's session at USD 47.02. The share price vacillated between USD 46.39 and USD 47.23. The stock recorded a trading volume of 2.57 million shares, which was above its 50-day daily average volume of 1.32 million shares and its 52-week average volume of 1.45 million shares. Over the last five days, Novo Nordisk A/S's shares have declined by 15.80% and in the past one month the stock has lost 17.93%. In addition, over the last three months the stock has lost 12.86% and year to date the shares have shed 19.04. Novo Nordisk A/S has a current dividend yield of 1.55%. Further, the company is trading at a price to earnings ratio of 23.39, compared to its historical PE ratio of 29.52. Additionally, the stock has a beta of 0.83.

--

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.